Joanna Chataway

Photo of Joanna Chataway
Research Group Director, Innovation, Health and Science, RAND Europe
Cambridge Office


Ph.D. in technology policy, The Open University; M.Phil. in development studies, Institute of Development Studies; B.Sc. in sociology, Colorado College

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Europe Media Relations at +44 (1223) 273-898, or email

More Experts


Joanna Chataway is research group director of Innovation, Health and Science at RAND Europe. She has more than 20 years of research and consultancy experience in the areas of innovation and social and economic development—particularly in the analysis and evaluation of investment in research and innovation and what sorts of policy, finance, and institutions are needed to facilitate translation of research into useful innovation. Her research has spanned public and private sectors and she has worked in industrially developed and developing countries.

Chataway is interested in global health and life science innovation, and has carried out a variety of research projects examining global health and agricultural public–private partnerships, factors influencing change within the pharmaceutical sector, and regulation of biotech and pharma.

In addition to her RAND appointment, Chataway is a professor at The Open University and is currently codirector of the Economic and Social Research Council (ESRC) Innogen Centre, which conducts a broad range of interdisciplinary research projects on social and economic aspects of innovation in life sciences. Innogen is based at The Open University and The University of Edinburgh. Chataway received her Ph.D. from The Open University.

Honors & Awards

  • Visiting Senior Researcher, University of Edinburgh
  • Phi Beta Kappa, Phi Beta Kappa Honors Society


  • Brexit referendum concept with stethoscope

    Brexit and Health Research: An Uncertain Picture

    The impact of leaving the EU on UK health research would depend greatly upon the terms and conditions of such a major change. But by exploring different scenarios, each with its own set of political and economic assumptions, we can get a picture of the potential impacts.

    May 23, 2016 Research Fortnight

  • Research, Science and Innovation Commissioner-designate Carlos Moedas of Portugal waits for the start of his hearing before the European Parliament's Committee on Industry, Research and Energy, at the EU Parliament in Brussels September 30, 2014

    Global Collaboration Needs a Firmer Evidence Base

    Policymakers should carry out a robust evaluation to assess the EU's research collaboration to date and analyze its impacts. This review should also compare the EU's portfolio with the collaborative research achievements of other players in international research. Such evidence would enhance the EU's research procurement strategy.

    Nov 10, 2014 Research Europe